Please switch to a supported browser to continue using this website.
Consider using the latest version of Google Chrome or Microsoft's Edge to view this website.
We have announced our 2024 Half Year Financial Results for the period ending 31st December 2023.
Announcement Information was released on Tuesday, 13th February 2024 (AEDT).
Please click here to view the full information, including the Webcast recording.
"As the COVID-19 pandemic evolves, CSL remains committed to safeguarding our patients, our donors and our people. In keeping with our values-based culture, CSL has taken precautions to ensure our employees and our facilities remain safe so we can continue to deliver on our promise to patients and public health." - Paul Perreault, CEO & Managing Director, CSL Limited